Pediatric Antibiotics Market to Surpass US$ 7,759.3 Mn by 2030 With CAGR of 2.3% | Torrent Pharmaceuticals Ltd., DAIICHI SANKYO COMPANY, LIMITED, Hikma Pharmaceuticals PLC

Overview:

Antibiotics are common treatment for some bacterial infection. Antibiotics kill the bacteria or prevent them their reproduction and spread. These medications are the most common prescribed drugs for children as they can save lives of patients suffering from major bacterial infections. These medications are administered orally and come in form of liquid suspension, capsules and tablets. However, antibiotics can be administered through intravenous routes. These medications are available in form of creams, ointments, and lotions for topical administration purpose.

Click Here to Get a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/5190

Market Drivers:

The cases of bacterial infection and mortality related to it among children is increasing around the world leading to increased demand for antibiotics, and this in turn is expected to fuel growth of the global pediatric antibiotics market during the forecast period. For instance, in June 2022, a singer-songwriter in America, Dolly Parton donated US$ 1million to Vanderbilt University Medical Center, to help research for pediatric infectious diseases, which will study, prevention, causes, treatments for the diseases in children suffering from cancer. Moreover, as per the World Health Organization (WHO) data, 14% of children, which is 740,180 children, under the age of 5 died due to pneumonia around the world.

Impact of COVID-19:

The virus outbreak in china impacted several industrial operations around the world. Many countries imposed lockdown regulations due to which, major market activities were hindered during that period. Production and demand declined due to lack of manpower and disrupted supply of raw materials. Moreover, several research activities were also affected by the pandemic, as governments declare to pause all the R&D by closing down research institutes temporarily. Due to all the preventative measures, the pediatric antibiotics market witnessed a negative impact the COVID-19 epidemic.

Regional Analysis:

Asia Pacific is anticipated to witness high growth in the global pediatric antibiotics market during the forecast period. This growth can be due to growing availability of funding for development and delivery of new treatments for infections that are drug-resistant. For instance, in March 2022, the Government of Australia granted funding to the Global Antibiotic Research and Development Partnership (GARDP), for supporting critical work in development drug-resistant infection treatment.

Key Takeaways:

• Global pediatric antibiotics market is estimated to show a CAGR of 2.3% over the forecast period. This is owing to growing initiatives by governments towards providing better facilities for children healthcare in developing regions. For instance, in November 2020, the Ministry of Public Health, Africa launched the Project AVENR that focuses on reducing mortality and morbidity among children by administrating azithromycin in every six months.
• Hospital Pharmacy segment among End Users is anticipated to witness significant growth in the global pediatric antibiotics market during the forecast period. This is due to growing number bacterial infection cases among kids around the world. For instance, in January 2021, the National Center for Biotechnology Information reported that nearly 80% of children are likely to suffer otitis media and nearly 80 to 90% of children are likely to suffer otitis media with effusion around the world.

Key Players:

Key players active in the global pediatric antibiotics market include Torrent Pharmaceuticals Ltd., DAIICHI SANKYO COMPANY, LIMITED, Hikma Pharmaceuticals PLC, Cipla Inc., Astellas Pharma, Inc, Novartis AG, Johnson & Johnson, GlaxoSmithKline Plc., Bristol-Myers Squibb Company, Glenmark Pharmaceuticals, Pfizer Inc., Aurobindo Pharma USA, Dr. Reddy’s Laboratories Ltd, Abbott., Bayer AG, and Teva Pharmaceuticals USA, Inc. 

Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/5190

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Pediatric Antibiotic Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Pediatric Antibiotic Industry Impact

Chapter 2 Global Pediatric Antibiotic Competition by Types, Applications, and Top Regions and Countries
2.1 Global Pediatric Antibiotic (Volume and Value) by Type
2.3 Global Pediatric Antibiotic (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Pediatric Antibiotic Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Pediatric Antibiotic Market Analysis
Chapter 6 East Asia Pediatric Antibiotic Market Analysis
Chapter 7 Europe Pediatric Antibiotic Market Analysis
Chapter 8 South Asia Pediatric Antibiotic Market Analysis
Chapter 9 Southeast Asia Pediatric Antibiotic Market Analysis
Chapter 10 Middle East Pediatric Antibiotic Market Analysis
Chapter 11 Africa Pediatric Antibiotic Market Analysis
Chapter 12 Oceania Pediatric Antibiotic Market Analysis
Chapter 13 South America Pediatric Antibiotic Market Analysis
Chapter 14 Company Profiles and Key Figures in Pediatric Antibiotic Business
Chapter 15 Global Pediatric Antibiotic Market Forecast (2022-2028)
Chapter 16 Conclusions
Research Methodology

Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/5190